Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Evolus, Inc. (EOLS) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/06/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
10/04/2023 SC 13G/A Flynn James E reports a 0% stake in Evolus, Inc.
08/14/2023 SC 13D/A Alphaeon 1 LLC reports a 0% stake in Evolus, Inc.
08/02/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/02/2023 8-K Quarterly results
07/27/2023 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
Docs: "Evolus Raises Full-Year Revenue Guidance on Record Second Quarter 2023 Revenue Evolus Raises Full-Year Revenue Guidance on Record Second Quarter 2023 Revenue Evolus Raises Full-Year Revenue Guidance on Record Second Quarter 2023 Revenue"
06/16/2023 SC 13G Stonepine Capital Management, LLC reports a 7.4% stake in Evolus, Inc.
06/09/2023 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
06/09/2023 EFFECT Form EFFECT - Notice of Effectiveness:
06/07/2023 S-3/A Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
05/09/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/09/2023 SC 13G/A MILLENNIUM MANAGEMENT LLC reports a 4.6% stake in EVOLUS, INC.
05/09/2023 8-K Quarterly results
Docs: "Evolus Reports First Quarter 2023 Results and Provides Business Update",
"Evolus Announces Expansion into U.S. Dermal Filler Market with EvolysseTM, a First-Generation Cold Technology HA by Symatese"
05/08/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
05/08/2023 ARS Form ARS - Annual Report to Security Holders:
04/26/2023 PRE 14A Form PRE 14A - Other preliminary proxy statements:
04/14/2023 S-3/A Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
03/13/2023 8-K Regulation FD Disclosure  Interactive Data
03/08/2023 S-3 Form S-3 - Registration statement under Securities Act of 1933:
03/08/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
03/08/2023 10-K Annual Report for the period ended December 31, 2022
03/08/2023 8-K Quarterly results
Docs: "Evolus Reports Fourth Quarter and Full Year 2022 Results and Provides Business Update"
02/14/2023 SC 13G/A FIRST MANHATTAN CO reports a 7.7% stake in Evolus, Inc.
02/10/2023 SC 13G/A Flynn James E reports a 5.9% stake in Evolus, Inc.
02/06/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
01/18/2023 8-K Quarterly results
12/13/2022 8-K Quarterly results
12/08/2022 8-K Quarterly results
11/08/2022 10-Q Quarterly Report for the period ended September 30, 2022
11/08/2022 8-K Quarterly results
09/09/2022 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
08/30/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Evolus Appoints Sandra Beaver as Chief Financial Officer"
08/02/2022 10-Q Quarterly Report for the period ended June 30, 2022
08/02/2022 8-K Quarterly results
Docs: "Evolus Reports Second Quarter 2022 Results and Provides Business Update"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy